Key result
The SweDen risk score predicted 1-year mortality after myocardial infarction with an area under the curve of 0.76 and a calibration slope of 1.03 in the validation cohort.
Why the study?
The authors aimed to derive and validate a patient-oriented risk score (SweDen score) to calculate 1-year mortality following myocardial infarction using factors known by patients themselves.
Does the patient-oriented SweDen risk score accurately predict 1-year mortality in patients after myocardial infarction?
Observational
Yes
Does the patient-oriented SweDen risk score accurately predict 1-year mortality in patients after myocardial infarction?
Answers are grounded in this paper and cite their sources.
The SweDen risk score is a validated, patient-friendly tool that accurately predicts 1-year mortality after myocardial infarction using six simple self-reported factors.
OBJECTIVES: Our aim was to derive, based on the SWEDEHEART registry, and validate, using the Western Denmark Heart registry, a patient-oriented risk score, the SweDen score, which could calculate the risk of 1-year mortality following a myocardial infarction (MI). METHODS: The factors included in the SweDen score were age, sex, smoking, diabetes, heart failure and statin use. These were chosen a priori by the SWEDEHEART steering group based on the premise that the factors were information known by the patients themselves. The score was evaluated using various statistical methods such as time-dependent receiver operating characteristics curves of the linear predictor, area under the curve metrics, Kaplan-Meier survivor curves and the calibration slope. RESULTS: The area under the curve values were 0.81 in the derivation data and 0.76 in the validation data. The Kaplan-Meier curves showed similar patient profiles across datasets. The calibration slope was 1.03 (95% CI 0.99 to 1.08) in the validation data using the linear predictor from the derivation data. CONCLUSIONS: The SweDen risk score is a novel tool created for patient use. The risk score calculator will be available online and presents mortality risk on a colour scale to simplify interpretation and to avoid exact life span expectancies. It provides a validated patient-oriented risk score predicting the risk of death within 1 year after suffering an MI, which visualises the benefit of statin use and smoking cessation in a simple way.
No takes yet. Share an insight, caveat, or question.
Rylance et al. (2022) conducted an observational in Myocardial infarction. SweDen risk score was evaluated on 1-year mortality (Calibration slope 1.03, 95% CI 0.99 to 1.08). The SweDen risk score predicted 1-year mortality after myocardial infarction with an area under the curve of 0.76 and a calibration slope of 1.03 in the validation cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: